Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Parkinson's Disease (PD)

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Arizona

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Scottsdale Arizona 85259

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Tucson Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tucson Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

California

PAREXEL
Glendale California 91206

Patients are needed to participate in a Phase 1 clinical research study evaluating a potential new treatment for Parkinson's disease.

View More ▼

Fountain Valley California 92708

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Fresno California 93710

A Phase 2 clinical study for patients with Parkinson's Disease

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fullerton California 92835

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Irvine California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Irvine California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

La Jolla California 92037

A clinical study for patients with Parkinson's Disease

Loma Linda California 92354

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Long Beach California 90806

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Los Angeles California 90033

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles California

Patients are needed to participate in a clinical research study of Various to evaluate Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps) or Sacral Nerve Stimulation

Mountain View California 94043

A clinical trial to evaluate treatments for patients with Parkinson's Disease

Napa California

Patients are needed to participate in a clinical research study of Various to evaluate Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps) or Sacral Nerve Stimulation

Pasadena California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Pasadena California 91105

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Pasadena California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Reseda California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Reseda California 91335

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

San Diego California

Patients are needed to participate in a clinical research study of Various to evaluate Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps) or Sacral Nerve Stimulation

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Activa PC+S for the treatment of Parkinson's Disease or Primary Dystonia

San Francisco California 94143

Patients are needed to participate in a clinical research study of AAV2-hAADC to evaluate Parkinson's Disease

San Francisco California 94121

Patients are needed to participate in a clinical research study of interventional MRI for implantation of DBS electrodes and DBS electrodes to evaluate Parkinson's Disease or Dystonia

Santa Ana California 92705

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Stanford California 94305

A clinical trial to evaluate treatments using ExAblate Transcranial System for patients with Parkinson's Disease

Torrance California 90505

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Valencia California 91355

Patients are needed to participate in a clinical research study of Deep Brain Stimulation to evaluate Parkinson's Disease

Ventura California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Ventura California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Colorado

Aurora Colorado 80045

A clinical research study of cannabidiol and placebo for the treatment of Parkinson's Disease

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Boulder Colorado

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Boulder Colorado

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Englewood Colorado 80113

A clinical trial to evaluate treatments using Activa PC+S for patients with Parkinson's Disease

View More ▼

Englewood Colorado 80113-2776

A Phase 2 clinical study for patients with Parkinson's Disease

Englewood Colorado 80113

Patients are needed to participate in a clinical research study evaluating Ropinirole Hydrochloride for the treatment of Parkinson's Disease

District of Columbia

Washington District of Columbia 20007

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Florida

Research Center
Miami Florida

A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 Oral Solution in Patients with Parkinson's Disease of Moderate Severity Responding to Immediate-Release Oral Levodopa/Carbidopa and Withdrawn from Levodopa/Carbidopa

Research Center
Orlando Florida

A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 Oral Solution in Patients with Parkinson's Disease of Moderate Severity Responding to Immediate-Release Oral Levodopa/Carbidopa and Withdrawn from Levodopa/Carbidopa

Palm Beach Neurological Center
Palm Beach Gardens Florida 33410

A Phase 3, Randomized , Double Blind, Placebo controlled Study. Investigating the Efficacy and Safety of CVT-301 (Levodopa inhalation Powder) in Parkinson's Disease With Motor Response Fluctuations (Off Phenomena)

University of South Florida - USF Health Byrd Alzheimer's Institute
Tampa Florida 33613

A 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease

University of South Florida - Morsani Center for Advanced Healthcare
Tampa Florida 33612

A 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease